NCT00286754

Brief Summary

The purpose of this study is to determine whether a stage-matched intervention (SMI) will lower BP and improve treatment adherence compared to usual care (UC) or a health education intervention (HEI) in veterans with uncontrolled BP. The study will also examine the effect of SMI on patient's health-related quality of life, satisfaction, acceptability and determine its cost-effectiveness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
533

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
Completed

Started Jul 2006

Longer than P75 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 3, 2006

Completed
5 months until next milestone

Study Start

First participant enrolled

July 1, 2006

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2010

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
3.6 years until next milestone

Results Posted

Study results publicly available

April 9, 2015

Completed
Last Updated

June 1, 2015

Status Verified

May 1, 2015

Enrollment Period

3.5 years

First QC Date

February 1, 2006

Results QC Date

January 21, 2015

Last Update Submit

May 8, 2015

Conditions

Keywords

HypertensionBehavior modificationRandomized controlled trialTreatment effectivenessTelemedicinePrevention

Outcome Measures

Primary Outcomes (2)

  • Blood Pressure Control

    Blood pressure Control at 6 months

    6 months

  • Systolic Blood Pressure

    Mean systolic Blood Pressure

    6 months

Secondary Outcomes (7)

  • Change in Proportion With BP Under Control From Baseline to 6 Months

    6 months

  • Change in Systolic Blood Pressure From Baseline to 6 Months

    Baseline and 6 months

  • Change in Number of Cardio Exercise Hours From Baseline to 6 Months

    baseline and 6 months

  • Change in Morisky Score From Baseline to 6 Months

    baseline and 6 months

  • Diet Stage of Change

    6 months

  • +2 more secondary outcomes

Study Arms (3)

Stage-matched intervention (SMI)

EXPERIMENTAL

Stage-matched intervention (SMI)

Behavioral: SMIBehavioral: HEIBehavioral: UC

Health Education Intervention (HEI)

ACTIVE COMPARATOR

Health Education Intervention (HEI)

Behavioral: SMIBehavioral: HEIBehavioral: UC

Usual Care (UC)

NO INTERVENTION

Usual Care (UC)

Interventions

SMIBEHAVIORAL

Stage-matched intervention

Stage-matched intervention (SMI)
HEIBEHAVIORAL

Health Education Intervention

Stage-matched intervention (SMI)
UCBEHAVIORAL

Usual Care

Stage-matched intervention (SMI)

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients receiving continuity of care in the outpatient clinics will be eligible. This will be operationalized as 2 visits in the previous year.
  • Adults (= 21 years) with hypertension, on antihypertensive medication for = 1 year, and who have current uncontrolled BP will be enrolled.
  • Patients with CVD:
  • chronic stable angina
  • unstable angina
  • uncomplicated myocardial infarction
  • coronary artery bypass surgery
  • percutaneous coronary angioplasty
  • atherectomy or stent placement
  • chronic stable angina pectoris
  • stable Class I or Class II congestive heart failure
  • stroke
  • peripheral vascular disease
  • will be entered into the study if the CVD event or diagnosis occurred = 6 months ago.

You may not qualify if:

  • Patients with limited life expectancy (\< 1 year) due to severe co-existing non-CVD disease such as:
  • terminal illnesses such as terminal cancer
  • CVD \< 6 months ago
  • Class III or IV CHF
  • severe psychiatric illness such as psychosis
  • manic depression
  • alcohol abuse (\> 21 drinks/week)
  • serious chronic conditions like AIDS
  • tuberculosis
  • lupus
  • and end-stage renal failure
  • will be excluded.
  • Lack of a landline telephone
  • Unable to follow the study protocol
  • Recent major surgery (\< 3 months)
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA New York Harbor Health Care System

New York, New York, 10010, United States

Location

Related Publications (4)

  • Ulmer M, Robinaugh D, Friedberg JP, Lipsitz SR, Natarajan S. Usefulness of a run-in period to reduce drop-outs in a randomized controlled trial of a behavioral intervention. Contemp Clin Trials. 2008 Sep;29(5):705-10. doi: 10.1016/j.cct.2008.04.005. Epub 2008 May 6.

  • Friedberg JP, Lipsitz SR, Natarajan S. Challenges and recommendations for blinding in behavioral interventions illustrated using a case study of a behavioral intervention to lower blood pressure. Patient Educ Couns. 2010 Jan;78(1):5-11. doi: 10.1016/j.pec.2009.04.009. Epub 2009 Jun 13.

  • Friedberg JP, Rodriguez MA, Watsula ME, Lin I, Wylie-Rosett J, Allegrante JP, Lipsitz SR, Natarajan S. Effectiveness of a tailored behavioral intervention to improve hypertension control: primary outcomes of a randomized controlled trial. Hypertension. 2015 Feb;65(2):440-6. doi: 10.1161/HYPERTENSIONAHA.114.03483. Epub 2014 Nov 17.

  • Rodriguez MA, Wang B, Hyoung S, Friedberg J, Wylie-Rosett J, Fang Y, Allegrante JP, Lipsitz SR, Natarajan S. Sustained Benefit of Alternate Behavioral Interventions to Improve Hypertension Control: A Randomized Clinical Trial. Hypertension. 2021 Jun;77(6):1867-1876. doi: 10.1161/HYPERTENSIONAHA.120.15192. Epub 2021 May 12.

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Sundar Natarajan, MD, Staff Physician
Organization
Department of Veterans Affairs

Study Officials

  • Sundar Natarajan, MD MSc

    VA New York Harbor Health Care System

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2006

First Posted

February 3, 2006

Study Start

July 1, 2006

Primary Completion

January 1, 2010

Study Completion

September 1, 2011

Last Updated

June 1, 2015

Results First Posted

April 9, 2015

Record last verified: 2015-05

Locations